Skip to main content
Log in

Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Magnesium sulfate is being investigated for the prevention or treatment of vasospasm following subarachnoid hemorrhage.

Patient

A 45-year-old woman suffered subarachnoid hemorrhage and developed after 8 days symptomatic vasospasm in the left middle cerebral artery (MCA) while she was receiving nimodipine prophylactically.

Methods and results

Transcranial Doppler monitoring was performed. Cerebral autoregulation was abolished in the left MCA. Despite this finding the administration of a bolus dose of MgSO4, followed by a continuous infusion in order to achieve serum magnesium levels in the range of 4–4.5 mg/dl (1.65–1.85 mmol/l), resulted in a marked decrease (12.2%) of the left MCA mean blood flow velocity, without clinically relevant change in systemic blood pressure (3%). This effect was maintained for at least 4 h. It did not prevent the development of ischemic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Dorsch NW (2002) Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128–133

    Article  PubMed  Google Scholar 

  2. Boet R, Mee E (2000) Magnesium sulfate in the management of patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 47:602–607

    CAS  PubMed  Google Scholar 

  3. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM (2002) Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:510–514

    CAS  PubMed  Google Scholar 

  4. Chia RY, Hughes RS, Morgan MK (2002) Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Clin Neurosci 9:279–281

    Article  CAS  PubMed  Google Scholar 

  5. Brewer RP, Parra A, Lynch J, Chilukuri V, Borel CO (2001) Cerebral blood flow velocity response to magnesium sulfate in patients after subarachnoid hemorrhage. J Neurosurg Anesthesiol 13:202–206

    Article  CAS  PubMed  Google Scholar 

  6. Pyne GJ, Cadoux-Hudson TAD, Clark JF (2001) Magnesium protection against in vitro cerebral vasospasm after subarachnoid hemorrhage. Br J Neurosurg 15:409–415

    Article  CAS  PubMed  Google Scholar 

  7. Giller GA (1991) A bedside test for cerebral autoregulation using transcranial Doppler ultrasound. Acta Neurochir (Wien) 108:7–14

    Google Scholar 

  8. Smielewski P, Czosnyka M, Kirkpatrick P, McEroy H, Rutkowska H, Pickard JD (1996) Assessment of cerebral autoregulation using carotid artery compression. Stroke 27:2197–2203

    CAS  PubMed  Google Scholar 

  9. Dernbach PD, Little JR, Jones SC, Ebrahim Z (1988) Altered cerebral autoregulation and carbon dioxide reactivity after aneurysmal SAH. Neurosurgery 22:822–826

    CAS  PubMed  Google Scholar 

  10. Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J (1998) Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 50:876–883

    PubMed  Google Scholar 

  11. Muir KW (2001) Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS Drugs 15:921–930

    CAS  PubMed  Google Scholar 

  12. Fuchs-Buder T, Tramer MR, Tassonyi E (1997) Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 9:324–328

    CAS  PubMed  Google Scholar 

  13. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M (1991) Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922–927

    CAS  PubMed  Google Scholar 

  14. van den Bergh WM, Zuur JK, Kamerling NA, van Asseldonk JT, Rinkel GJ, Tulleken CA, Nicolay K (2002) Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. J Neurosurg 97:416–422

    PubMed  Google Scholar 

  15. Lundvrook GL, James MF, Upton RN (1999) The effect of magnesium sulfate on cerebral blood flow velocity, cardiovascular variables, and arterial carbon dioxide tension in awake sheep. J Neurosurg Anesthesiol 11:96–101

    PubMed  Google Scholar 

  16. Sadeh M (1989) Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 20:1273–1275

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Hantson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barile, M., van de Wyngaert, F., Mbia, JJ.E. et al. Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage. Intensive Care Med 29, 1182–1185 (2003). https://doi.org/10.1007/s00134-003-1752-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1752-9

Keywords

Navigation